Vaxart Inc (VXRT)

7.16
+0.23(+3.32%)
  • Volume:
    5,925,069
  • Bid/Ask:
    7.16/7.18
  • Day's Range:
    6.70 - 7.345

VXRT Overview

Prev. Close
6.93
Day's Range
6.7 - 7.345
Revenue
4.05M
Open
6.76
52 wk Range
2.235 - 24.84
EPS
-0.46
Volume
5,925,069
Market Cap
843.44M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
17,857,824
P/E Ratio
-
Beta
0.32
1-Year Change
169.65%
Shares Outstanding
117,963,912
Next Earnings Date
Aug 12, 2021
What is your sentiment on Vaxart Inc?
or
Vote to see community's results!

Vaxart Inc News

Vaxart Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralSellSell
Technical IndicatorsBuyStrong BuySellSellBuy
SummaryStrong BuyStrong BuyNeutralSellNeutral

Vaxart Inc Company Profile

Vaxart Inc Company Profile

Employees
28

Vaxart, Inc., formerly Aviragen Therapeutics, Inc., is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The Company has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics in Phase IIb SPIRITUS trial; BTA585, an oral fusion (F) protein inhibitor in Phase II development for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in Phase II development for condyloma caused by human papillomavirus Types 6 and 11. It has preclinical RSV non-fusion inhibitor program. It has focused its research and drug development capabilities on discovering and developing small molecule compounds that can prevent or treat infectious diseases.

Read More
  • Friday will be better.
    0
    • hope to 15+=)
      2
      • expecting 14 usd at least in R2. Not a reckon. future will tell :)
        0
        • what is   "R2" sorr for my french(c)
          0
      • I bought the dip ;) let 's see !
        1
        • back to 5+ range?
          1
          • Yea unfortunetly i think thats where its heading but ill load up once it breaks under 5.5 tomotrow is the last chance this can rebound high if it doesnt this stock will be quiet for 2-6 months
            0
        • Interesting updatehttps://www.entrepreneur.com/article/371142
          1
          • nothing to be excited about, its called paid infomercial (and lazy plagarism). You read carefully and its just info lifted from other stock analyst.  I cringe at the last tag line "With so much exciting news surrounding Vaxart, will you consider watching VXRT stock?"
            0
        • Should turn green soon......
          2
          • ma che dici?
            0
        • Let's make some money today!!
          0
          • long or short?
            0
        • Finalmente funziona
          1
          • trash
            1
            • What a piece of ****this is!! This is going to ****sooner or later AGAIN
              0
              • Website Down
                0
                • To the moon ? :-)
                  0
                  • Website Down!
                    1
                    • Down!
                      0
                      • My Investing.com's not moving!
                        0
                        • same
                          1
                      • Anybody?
                        0
                        • WEbsite down?
                          0
                          • idk sumthin aint right
                            0
                        • crash 25% during mkt, pop 21% after mkt. Release poor earnings before mkt, release data on oral vacs after mkt. Wow, nicely done for the insiders, clap clap
                          0
                          • As usual with VXRT.
                            0
                          • why do they like this? At least, we want to save the money for huge ph3 test without any support
                            0
                        • So the news with video calls make big falls, with letters do big rise. The news was same. Thus I have to make the conclusion that only problem of this company is the look of CEO. It is rediculous, but have to admit it is positive. Dang
                          0
                          • It was news of bad quarter earnings that makes fall and news if tablet vaccine beinf effective make rise after hours
                            0
                        • https://finance.yahoo.com/news/data-vaxart-oral-covid-19-210600367.html
                          1
                          • this stock is bipolar
                            0
                            • There is no logic for this stock.
                              0
                              • Don'r forget, diamond hands! Haver faith!
                                0
                                • This stock is a bipolar ride lol
                                  0
                                • JAH Annlol!.. i wish SRNE did this AH 🤷‍♂️
                                  0
                                • mark slaughterme too! Srne is testing my patience. We need a big move soon.
                                  0
                              • Hmm. Pretty weird after hours action.
                                0
                                • ya like no insider stuff going on there huh😂
                                  0
                                • Not weird because news was released
                                  0
                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.